id	sid	eid	entity	type
ghmj-960	1	1	myanmar	GPE
ghmj-960	1	2	thailand	GPE
ghmj-960	1	3	global health management journal	ORG
ghmj-960	1	4	2023	CARDINAL
ghmj-960	1	5	6	CARDINAL
ghmj-960	1	6	2	CARDINAL
ghmj-960	1	7	indonesian	NORP
ghmj-960	1	8	rani tiyas	PERSON
ghmj-960	1	9	2 1	CARDINAL
ghmj-960	1	10	mada university	ORG
ghmj-960	1	11	yogyakarta	GPE
ghmj-960	1	12	indonesia	GPE
ghmj-960	1	13	2	CARDINAL
ghmj-960	1	14	semarang	GPE
ghmj-960	1	15	indonesia	GPE
ghmj-960	2	1	doi	PERSON
ghmj-960	2	2	10.35898	CARDINAL
ghmj-960	2	3	covid-19	ORG
ghmj-960	2	4	the end of 2020	DATE
ghmj-960	3	1	eua	ORG
ghmj-960	4	1	astra zeneca	ORG
ghmj-960	4	2	johnson & johnson	ORG
ghmj-960	5	1	covid-19	ORG
ghmj-960	6	1	one	CARDINAL
ghmj-960	7	1	covid-19	ORG
ghmj-960	10	1	scopus	ORG
ghmj-960	10	2	proquest	ORG
ghmj-960	10	3	2020	DATE
ghmj-960	10	4	2022	CARDINAL
ghmj-960	11	1	9	CARDINAL
ghmj-960	12	1	only 28%	PERCENT
ghmj-960	12	2	postcovid-19	TIME
ghmj-960	12	3	45-49 years old	DATE
ghmj-960	13	1	covid-19	ORG
ghmj-960	14	1	igg	ORG
ghmj-960	14	2	covid-19	ORG
ghmj-960	15	1	igg	ORG
ghmj-960	15	2	covid-19	ORG
ghmj-960	16	1	covid-19	ORG
ghmj-960	19	1	9	CARDINAL
ghmj-960	19	2	2023	CARDINAL
ghmj-960	19	3	8	CARDINAL
ghmj-960	19	4	18	CARDINAL
ghmj-960	19	5	yayasan aliansi cendekiawan	PERSON
ghmj-960	19	6	indonesia	GPE
ghmj-960	19	7	thailand	GPE
ghmj-960	19	8	indonesian	NORP
ghmj-960	20	1	4.0	CARDINAL
ghmj-960	20	2	4.0	CARDINAL
ghmj-960	20	3	1	CARDINAL
ghmj-960	21	1	covid-19	ORG
ghmj-960	22	1	more than 600 million	CARDINAL
ghmj-960	22	2	march 2020	DATE
ghmj-960	22	3	the world health organization	ORG
ghmj-960	23	1	covid-19	PERSON
ghmj-960	24	1	covid-19	DATE
ghmj-960	24	2	mailto:ardhinanugrahaeni@gmail.com https://doi.org/10.35898/ghmj-62960 nugrahaeni & budiyanti ghmj	ORG
ghmj-960	24	3	2023	CARDINAL
ghmj-960	24	4	6	CARDINAL
ghmj-960	24	5	2 58	DATE
ghmj-960	25	1	eua	ORG
ghmj-960	26	1	the world health organization	ORG
ghmj-960	26	2	covid-19	PRODUCT
ghmj-960	26	3	johnson & johnson's	ORG
ghmj-960	28	1	covid-19	PRODUCT
ghmj-960	30	1	dermatologic reactions	PERSON
ghmj-960	30	2	covid-19	DATE
ghmj-960	33	1	paf	ORG
ghmj-960	35	1	2022	CARDINAL
ghmj-960	37	1	2	CARDINAL
ghmj-960	39	1	covid-19	PRODUCT
ghmj-960	41	1	scopus	ORG
ghmj-960	41	2	proquest	ORG
ghmj-960	41	3	2020	DATE
ghmj-960	41	4	2022	CARDINAL
ghmj-960	42	1	post-covid-19	EVENT
ghmj-960	44	1	four	CARDINAL
ghmj-960	44	2	scopus	ORG
ghmj-960	44	3	proquest	ORG
ghmj-960	49	1	102	CARDINAL
ghmj-960	49	2	430	CARDINAL
ghmj-960	50	1	93	CARDINAL
ghmj-960	50	2	only 9	CARDINAL
ghmj-960	51	1	1	CARDINAL
ghmj-960	52	1	430	CARDINAL
ghmj-960	52	2	102	CARDINAL
ghmj-960	52	3	328	CARDINAL
ghmj-960	52	4	93	CARDINAL
ghmj-960	52	5	59	CARDINAL
ghmj-960	52	6	global health management journal	ORG
ghmj-960	52	7	2023	CARDINAL
ghmj-960	53	1	6	CARDINAL
ghmj-960	53	2	2	CARDINAL
ghmj-960	53	3	1	CARDINAL
ghmj-960	54	1	parodi a. cutaneous	PERSON
ghmj-960	54	2	covid-19	PRODUCT
ghmj-960	54	3	2021	CARDINAL
ghmj-960	54	4	covid-19	PERSON
ghmj-960	54	5	march 2021 to june 2021	DATE
ghmj-960	54	6	only 15%	PERCENT
ghmj-960	54	7	covid-19	ORG
ghmj-960	56	1	ten	CARDINAL
ghmj-960	57	1	four	CARDINAL
ghmj-960	57	2	24 hours	TIME
ghmj-960	57	3	24 hours	TIME
ghmj-960	57	4	grieco t	PERSON
ghmj-960	57	5	ambrosio l	ORG
ghmj-960	58	1	2022	CARDINAL
ghmj-960	58	2	1	CARDINAL
ghmj-960	58	3	2021	DATE
ghmj-960	58	4	10 december 2021	DATE
ghmj-960	58	5	only 160	CARDINAL
ghmj-960	58	6	two	CARDINAL
ghmj-960	59	1	twenty	CARDINAL
ghmj-960	61	1	only 17.86%	PERCENT
ghmj-960	61	2	3.12	CARDINAL
ghmj-960	62	1	covid-19	ORG
ghmj-960	63	1	muñoz-santos c	ORG
ghmj-960	63	2	galváncasas cr	PERSON
ghmj-960	63	3	riesco	PERSON
ghmj-960	63	4	nebreda	PERSON
ghmj-960	64	1	spanish	NORP
ghmj-960	64	2	405	CARDINAL
ghmj-960	64	3	2021	CARDINAL
ghmj-960	64	4	16 february	DATE
ghmj-960	64	5	15 may 2021	DATE
ghmj-960	65	1	21 days	DATE
ghmj-960	65	2	covid-19	CARDINAL
ghmj-960	69	1	only 405	CARDINAL
ghmj-960	69	2	50.7	CARDINAL
ghmj-960	69	3	17.6	CARDINAL
ghmj-960	69	4	80.2%	PERCENT
ghmj-960	70	1	40.2%	PERCENT
ghmj-960	70	2	36.3%	PERCENT
ghmj-960	70	3	23.5%	PERCENT
ghmj-960	71	1	32.1%	PERCENT
ghmj-960	71	2	14.6%	PERCENT
ghmj-960	71	3	morbiliform	PERSON
ghmj-960	71	4	8.9%	PERCENT
ghmj-960	71	5	6.4%	PERCENT
ghmj-960	71	6	4.9%	PERCENT
ghmj-960	71	7	4%	PERCENT
ghmj-960	72	1	13.8%	PERCENT
ghmj-960	74	1	24	CARDINAL
ghmj-960	74	2	40.7%	PERCENT
ghmj-960	75	1	astrazeneca	PERSON
ghmj-960	75	2	20	CARDINAL
ghmj-960	75	3	33.9%	PERCENT
ghmj-960	76	1	15	CARDINAL
ghmj-960	76	2	25.9%	PERCENT
ghmj-960	77	1	only 46	CARDINAL
ghmj-960	77	2	78%	PERCENT
ghmj-960	77	3	59	CARDINAL
ghmj-960	78	1	first	ORDINAL
ghmj-960	78	2	covid-19	ORG
ghmj-960	79	1	covid-19	ORG
ghmj-960	80	1	2023	CARDINAL
ghmj-960	81	1	6	CARDINAL
ghmj-960	81	2	2 60	CARDINAL
ghmj-960	81	3	shahidi dadras m	ORG
ghmj-960	81	4	salari m	ORG
ghmj-960	81	5	diab	PERSON
ghmj-960	81	6	covid-19	ORG
ghmj-960	81	7	867	CARDINAL
ghmj-960	81	8	2022	CARDINAL
ghmj-960	82	1	first	ORDINAL
ghmj-960	83	1	covid-19	PRODUCT
ghmj-960	85	1	30%	PERCENT
ghmj-960	85	2	iran	GPE
ghmj-960	85	3	covid-19	DATE
ghmj-960	86	1	covid-19	ORG
ghmj-960	87	1	25	CARDINAL
ghmj-960	88	1	bruusgaardmouritsen m	PERSON
ghmj-960	88	2	jensen bm	PERSON
ghmj-960	88	3	poulsen lk	PERSON
ghmj-960	88	4	johansen jd	PERSON
ghmj-960	89	1	2022	CARDINAL
ghmj-960	89	2	3000/6000	CARDINAL
ghmj-960	89	3	20000	CARDINAL
ghmj-960	90	1	three	CARDINAL
ghmj-960	91	1	only 8	CARDINAL
ghmj-960	91	2	407	CARDINAL
ghmj-960	91	3	3	CARDINAL
ghmj-960	91	4	80	CARDINAL
ghmj-960	93	1	20000	CARDINAL
ghmj-960	94	1	nuovo g	PERSON
ghmj-960	94	2	mulvey j	PERSON
ghmj-960	94	3	laurence j	PERSON
ghmj-960	95	1	covid-19 2021	ORG
ghmj-960	95	2	covid-19	ORG
ghmj-960	95	3	covid-19	GPE
ghmj-960	96	1	weill cornell	PERSON
ghmj-960	96	2	tulsa	GPE
ghmj-960	96	3	oklahoma	GPE
ghmj-960	96	4	march 2020 to june 2021	DATE
ghmj-960	97	1	covid-19	ORG
ghmj-960	99	1	almuhizi f	PERSON
ghmj-960	99	2	ton-leclerc s	ORG
ghmj-960	99	3	fein m	ORG
ghmj-960	99	4	garvey lh	PERSON
ghmj-960	100	1	covid-19	DATE
ghmj-960	100	2	first	ORDINAL
ghmj-960	100	3	2022	CARDINAL
ghmj-960	100	4	covid-19	PRODUCT
ghmj-960	101	1	first	ORDINAL
ghmj-960	101	2	the mcgill university health center	ORG
ghmj-960	103	1	second	ORDINAL
ghmj-960	103	2	six	CARDINAL
ghmj-960	103	3	142	CARDINAL
ghmj-960	105	1	30 minutes	TIME
ghmj-960	105	2	first	ORDINAL
ghmj-960	105	3	covid-19	PRODUCT
ghmj-960	106	1	first	ORDINAL
ghmj-960	107	1	61	CARDINAL
ghmj-960	107	2	2023	CARDINAL
ghmj-960	107	3	6	CARDINAL
ghmj-960	107	4	2	CARDINAL
ghmj-960	107	5	pitlick mm	PERSON
ghmj-960	107	6	joshi ay	PERSON
ghmj-960	107	7	2022	CARDINAL
ghmj-960	107	8	19 january 2021	DATE
ghmj-960	107	9	30 april 2021	DATE
ghmj-960	108	1	twelve	CARDINAL
ghmj-960	108	2	jacksonville	GPE
ghmj-960	108	3	florida	GPE
ghmj-960	108	4	rochester	GPE
ghmj-960	108	5	minnesota	GPE
ghmj-960	108	6	covid-19	DATE
ghmj-960	109	1	covid-19	PRODUCT
ghmj-960	110	1	eleven	CARDINAL
ghmj-960	110	2	first	ORDINAL
ghmj-960	110	3	covid-19	ORG
ghmj-960	111	1	covid-19	DATE
ghmj-960	112	1	macy e	ORG
ghmj-960	112	2	pandya s	PERSON
ghmj-960	112	3	m.shi j	PERSON
ghmj-960	112	4	chung j	PERSON
ghmj-960	112	5	2022	CARDINAL
ghmj-960	112	6	california	GPE
ghmj-960	113	1	covid-19	PRODUCT
ghmj-960	113	2	16	CARDINAL
ghmj-960	113	3	2020	DATE
ghmj-960	113	4	11 march 2021	DATE
ghmj-960	115	1	covid-19	PRODUCT
ghmj-960	116	1	only 15200	CARDINAL
ghmj-960	117	1	16.3%	PERCENT
ghmj-960	117	2	first	ORDINAL
ghmj-960	117	3	12.5%	PERCENT
ghmj-960	117	4	second	ORDINAL
ghmj-960	118	1	3	CARDINAL
ghmj-960	118	2	a. prevalence	PERSON
ghmj-960	118	3	covid-19	PRODUCT
ghmj-960	118	4	2021	CARDINAL
ghmj-960	119	1	2022	CARDINAL
ghmj-960	119	2	only 21	CARDINAL
ghmj-960	119	3	200	CARDINAL
ghmj-960	119	4	covid-19	CARDINAL
ghmj-960	120	1	fifteen (71%	PERCENT
ghmj-960	121	1	ten	CARDINAL
ghmj-960	121	2	covid-19	ORG
ghmj-960	122	1	four	CARDINAL
ghmj-960	122	2	24 hours	TIME
ghmj-960	122	3	24 hours	TIME
ghmj-960	123	1	astrazeneca	ORG
ghmj-960	123	2	brooks et al.	ORG
ghmj-960	123	3	2022	CARDINAL
ghmj-960	124	1	messenger rna	PERSON
ghmj-960	124	2	2	CARDINAL
ghmj-960	125	1	bianchi et al.	PERSON
ghmj-960	125	2	2021	CARDINAL
ghmj-960	128	1	covid-19	PERSON
ghmj-960	128	2	2021	CARDINAL
ghmj-960	129	1	only 28%	PERCENT
ghmj-960	130	1	covid-19	PERSON
ghmj-960	130	2	grieco et al.	PERSON
ghmj-960	130	3	2022	CARDINAL
ghmj-960	131	1	covid-19	DATE
ghmj-960	131	2	45-49 years old	DATE
ghmj-960	132	1	covid-19	PERSON
ghmj-960	132	2	cugno et al.	PERSON
ghmj-960	132	3	2021	CARDINAL
ghmj-960	133	1	2023	CARDINAL
ghmj-960	133	2	6	CARDINAL
ghmj-960	133	3	2 62	DATE
ghmj-960	133	4	spanish	LANGUAGE
ghmj-960	133	5	only 21.1%	PERCENT
ghmj-960	133	6	covid-19	PRODUCT
ghmj-960	134	1	català et al.	PERSON
ghmj-960	134	2	2021	CARDINAL
ghmj-960	136	1	40.7%	PERCENT
ghmj-960	136	2	24	CARDINAL
ghmj-960	137	1	astrazeneca	ORG
ghmj-960	137	2	20	CARDINAL
ghmj-960	137	3	33.9%	PERCENT
ghmj-960	138	1	15	CARDINAL
ghmj-960	138	2	25.9%	PERCENT
ghmj-960	139	1	only 46	CARDINAL
ghmj-960	139	2	78%	PERCENT
ghmj-960	139	3	59	CARDINAL
ghmj-960	140	1	first	ORDINAL
ghmj-960	140	2	covid-19	ORG
ghmj-960	141	1	brooks et al	ORG
ghmj-960	141	2	2022	CARDINAL
ghmj-960	142	1	first	ORDINAL
ghmj-960	142	2	covid-19	PRODUCT
ghmj-960	143	1	five days	DATE
ghmj-960	143	2	the 60 years old	DATE
ghmj-960	144	1	caucasian	NORP
ghmj-960	144	2	48 years old	DATE
ghmj-960	144	3	3 hours	TIME
ghmj-960	144	4	second	ORDINAL
ghmj-960	144	5	2021	CARDINAL
ghmj-960	145	1	39 years old	DATE
ghmj-960	146	1	second	ORDINAL
ghmj-960	146	2	astra zeneca	ORG
ghmj-960	146	3	2 weeks	DATE
ghmj-960	146	4	suan	GPE
ghmj-960	146	5	lee	PERSON
ghmj-960	146	6	2022	CARDINAL
ghmj-960	147	1	iran	GPE
ghmj-960	147	2	25	CARDINAL
ghmj-960	147	3	astra zeneca	ORG
ghmj-960	148	1	astra zeneca	ORG
ghmj-960	148	2	2022	CARDINAL
ghmj-960	149	1	thailand	GPE
ghmj-960	149	2	35,229	CARDINAL
ghmj-960	149	3	2022	CARDINAL
ghmj-960	150	1	the coronavac vaccine administration	ORG
ghmj-960	150	2	turkey	GPE
ghmj-960	150	3	about 0.8%	PERCENT
ghmj-960	150	4	2022	CARDINAL
ghmj-960	151	1	turkey	GPE
ghmj-960	151	2	2022	CARDINAL
ghmj-960	152	1	years	DATE
ghmj-960	152	2	first	ORDINAL
ghmj-960	153	1	10 minutes	TIME
ghmj-960	153	2	kaya	PERSON
ghmj-960	153	3	2022	CARDINAL
ghmj-960	154	1	four	CARDINAL
ghmj-960	154	2	coronavac administration	ORG
ghmj-960	155	1	three	CARDINAL
ghmj-960	155	2	first	ORDINAL
ghmj-960	156	1	one	CARDINAL
ghmj-960	156	2	second	ORDINAL
ghmj-960	156	3	coronavac	ORG
ghmj-960	156	4	akdaş et al.	PERSON
ghmj-960	156	5	2022	CARDINAL
ghmj-960	158	1	2022	CARDINAL
ghmj-960	159	1	2000	CARDINAL
ghmj-960	163	1	2021	CARDINAL
ghmj-960	165	1	2021	CARDINAL
ghmj-960	166	1	non-ige-	PERSON
ghmj-960	166	2	ige	PERSON
ghmj-960	166	3	covid-19	DATE
ghmj-960	166	4	grieco et al.	PERSON
ghmj-960	166	5	2022	CARDINAL
ghmj-960	168	1	80	CARDINAL
ghmj-960	168	2	johnson & johnson	ORG
ghmj-960	168	3	covid-19	ORG
ghmj-960	169	1	two	CARDINAL
ghmj-960	170	1	80	CARDINAL
ghmj-960	170	2	80	DATE
ghmj-960	170	3	almuhizi et al.	PERSON
ghmj-960	170	4	2022	CARDINAL
ghmj-960	174	1	63	CARDINAL
ghmj-960	174	2	2023	CARDINAL
ghmj-960	174	3	6	CARDINAL
ghmj-960	174	4	2	CARDINAL
ghmj-960	174	5	2022	CARDINAL
ghmj-960	175	1	2022	CARDINAL
ghmj-960	176	1	three	CARDINAL
ghmj-960	176	2	four	CARDINAL
ghmj-960	176	3	second	ORDINAL
ghmj-960	176	4	covid-19	PRODUCT
ghmj-960	177	1	covid-19	PERSON
ghmj-960	178	1	2022	CARDINAL
ghmj-960	179	1	ige	PERSON
ghmj-960	179	2	igg	ORG
ghmj-960	180	1	ige	PERSON
ghmj-960	180	2	2022	CARDINAL
ghmj-960	180	3	second	ORDINAL
ghmj-960	180	4	first	ORDINAL
ghmj-960	180	5	half	CARDINAL
ghmj-960	181	1	grieco et al.	PERSON
ghmj-960	181	2	2022	CARDINAL
ghmj-960	182	1	2021	CARDINAL
ghmj-960	183	1	omalizumab	PERSON
ghmj-960	183	2	bernstein et al.	PERSON
ghmj-960	183	3	2020	DATE
ghmj-960	184	1	2022	CARDINAL
ghmj-960	185	1	up to 40 mg	QUANTITY
ghmj-960	185	2	daily	DATE
ghmj-960	187	1	2022	CARDINAL
ghmj-960	188	1	2 days	DATE
ghmj-960	190	1	bermingham et al.	PERSON
ghmj-960	190	2	2021	CARDINAL
ghmj-960	191	1	4	CARDINAL
ghmj-960	191	2	80	CARDINAL
ghmj-960	192	1	2021	CARDINAL
ghmj-960	193	1	2000	DATE
ghmj-960	194	1	bianchi et al.	PERSON
ghmj-960	194	2	2021	CARDINAL
ghmj-960	195	1	2000	DATE
ghmj-960	196	1	1	CARDINAL
ghmj-960	196	2	2021	CARDINAL
ghmj-960	201	1	2022	CARDINAL
ghmj-960	202	1	cdc	ORG
ghmj-960	202	2	4 hours	TIME
ghmj-960	202	3	2021	CARDINAL
ghmj-960	203	1	ige	PERSON
ghmj-960	203	2	igg	ORG
ghmj-960	204	1	ige	PERSON
ghmj-960	204	2	2022	CARDINAL
ghmj-960	205	1	less than 30 minutes	TIME
ghmj-960	205	2	first	ORDINAL
ghmj-960	205	3	second	ORDINAL
ghmj-960	205	4	2022	CARDINAL
ghmj-960	207	1	2021	CARDINAL
ghmj-960	208	1	2023	CARDINAL
ghmj-960	208	2	6	CARDINAL
ghmj-960	208	3	2 64 5	DATE
ghmj-960	209	1	covid-19	ORG
ghmj-960	210	1	igg	ORG
ghmj-960	210	2	covid-19	ORG
ghmj-960	211	1	covid-19	PRODUCT
ghmj-960	215	1	akdaş	PERSON
ghmj-960	215	2	b.	GPE
ghmj-960	215	3	erdem	GPE
ghmj-960	215	4	ö.	GPE
ghmj-960	215	5	m. o., & i̇lter	PERSON
ghmj-960	215	6	2021	CARDINAL
ghmj-960	216	1	covid-19	PERSON
ghmj-960	216	2	six	CARDINAL
ghmj-960	217	1	the european academy	ORG
ghmj-960	217	2	jeadv	PERSON
ghmj-960	217	3	35(12	CARDINAL
ghmj-960	218	1	ton-leclerc	ORG
ghmj-960	218	2	s., fein	ORG
ghmj-960	218	3	m., tsoukas	PERSON
ghmj-960	218	4	l.h.	GPE
ghmj-960	218	5	lee	PERSON
ghmj-960	218	6	d.,et al	PERSON
ghmj-960	218	7	2022	CARDINAL
ghmj-960	219	1	covid-19	DATE
ghmj-960	219	2	first	ORDINAL
ghmj-960	221	1	february 2022	DATE
ghmj-960	222	1	https://doi.org/10.3389/falgy.2022.825164 bermingham	PERSON
ghmj-960	222	2	w.h.	GPE
ghmj-960	222	3	m.r.	GPE
ghmj-960	222	4	huissoon	GPE
ghmj-960	222	5	a.p.	GPE
ghmj-960	222	6	krishna	GPE
ghmj-960	222	7	m.t.	GPE
ghmj-960	222	8	2021	CARDINAL
ghmj-960	224	1	british	NORP
ghmj-960	224	2	2021)185	CARDINAL
ghmj-960	225	1	https://doi.org/10.1111/bjd.20495 bernstein	PERSON
ghmj-960	225	2	j.a.	GPE
ghmj-960	225	3	singh	GPE
ghmj-960	225	4	rao	PERSON
ghmj-960	225	5	m.b.	GPE
ghmj-960	225	6	berendts	NORP
ghmj-960	225	7	x.	GPE
ghmj-960	225	8	2020	DATE
ghmj-960	226	1	benralizumab	PERSON
ghmj-960	227	1	2020	DATE
ghmj-960	227	2	383:1389	CARDINAL
ghmj-960	228	1	10.1056	CARDINAL
ghmj-960	228	2	nejmc2016395 bianchi	PERSON
ghmj-960	228	3	l.	GPE
ghmj-960	228	4	biondi	PERSON
ghmj-960	228	5	k.	PERSON
ghmj-960	228	6	tramontana	PERSON
ghmj-960	228	7	m.	PERSON
ghmj-960	228	8	l.	PERSON
ghmj-960	228	9	2021	CARDINAL
ghmj-960	230	1	wiley allergy	PERSON
ghmj-960	231	1	2021	CARDINAL
ghmj-960	231	2	22	CARDINAL
ghmj-960	231	3	10.1111	CARDINAL
ghmj-960	231	4	10.1111	CARDINAL
ghmj-960	231	5	brooks, s.g.	ORG
ghmj-960	231	6	de jong	PERSON
ghmj-960	231	7	m., sussman	ORG
ghmj-960	231	8	2022	CARDINAL
ghmj-960	232	1	covid-19	PRODUCT
ghmj-960	233	1	sage allergy &	ORG
ghmj-960	233	2	13	CARDINAL
ghmj-960	234	1	m., jensen	PERSON
ghmj-960	234	2	b.m.	GPE
ghmj-960	234	3	poulsen	PERSON
ghmj-960	234	4	l.k.	GPE
ghmj-960	234	5	johansen	PERSON
ghmj-960	234	6	j.d.	GPE
ghmj-960	234	7	garvey	ORG
ghmj-960	234	8	l.h.	GPE
ghmj-960	234	9	2022	CARDINAL
ghmj-960	236	1	149	CARDINAL
ghmj-960	236	2	1	CARDINAL
ghmj-960	236	3	168	CARDINAL
ghmj-960	237	1	m.	PERSON
ghmj-960	237	2	e., parodi,	ORG
ghmj-960	237	3	a.	PERSON
ghmj-960	237	4	2021	CARDINAL
ghmj-960	238	1	covid-19	PERSON
ghmj-960	238	2	80	CARDINAL
ghmj-960	239	1	korean	NORP
ghmj-960	239	2	2021	CARDINAL
ghmj-960	239	3	10(3	CARDINAL
ghmj-960	239	4	298–300	CARDINAL
ghmj-960	240	1	m.	PERSON
ghmj-960	240	2	e., parodi,	ORG
ghmj-960	240	3	a.	PERSON
ghmj-960	240	4	2021	CARDINAL
ghmj-960	241	1	covid-19	PRODUCT
ghmj-960	242	1	10	CARDINAL
ghmj-960	242	2	2	CARDINAL
ghmj-960	242	3	265	CARDINAL
ghmj-960	243	1	https://doi.org/10.1002/iid3.568 català	PERSON
ghmj-960	243	2	muñoz-santos c	ORG
ghmj-960	243	3	riesco	PERSON
ghmj-960	243	4	nebreda	PERSON
ghmj-960	243	5	2022	CARDINAL
ghmj-960	244	1	spanish	NORP
ghmj-960	244	2	405	CARDINAL
ghmj-960	245	1	british	NORP
ghmj-960	245	2	2022)186	CARDINAL
ghmj-960	246	1	https://doi.org/10.1111/bjd.20639 cugno	PERSON
ghmj-960	246	2	consonni	GPE
ghmj-960	246	3	d.	NORP
ghmj-960	246	4	lombardi, a.	ORG
ghmj-960	246	5	m., renteria	ORG
ghmj-960	246	6	s.u.	GPE
ghmj-960	246	7	2021	CARDINAL
ghmj-960	247	1	bnt162b2mrna covid-19	PERSON
ghmj-960	248	1	2021	CARDINAL
ghmj-960	248	2	1011	CARDINAL
ghmj-960	248	3	https://doi.org/10.3390/vaccines9091011	ORG
ghmj-960	248	4	k.	PERSON
ghmj-960	248	5	s.	GPE
ghmj-960	248	6	metin	GPE
ghmj-960	248	7	z.	PERSON
ghmj-960	248	8	dursun	GPE
ghmj-960	248	9	r., & abdelmaksoud	ORG
ghmj-960	248	10	a.	PERSON
ghmj-960	248	11	2022	CARDINAL
ghmj-960	249	1	coronavac®	ORG
ghmj-960	250	1	47(1	DATE
ghmj-960	250	2	171–173	CARDINAL
ghmj-960	251	1	zelin	GPE
ghmj-960	251	2	e.,	GPE
ghmj-960	251	3	e.	PERSON
ghmj-960	251	4	pinzani	PERSON
ghmj-960	251	5	2021	CARDINAL
ghmj-960	252	1	covid-19	PRODUCT
ghmj-960	252	2	italy	GPE
ghmj-960	253	1	the european academy	ORG
ghmj-960	253	2	jeadv	PERSON
ghmj-960	253	3	35(9	DATE
ghmj-960	253	4	e551	DATE
ghmj-960	254	1	https://doi.org/10.1111/jdv.17343 grieco	PERSON
ghmj-960	254	2	f.	PERSON
ghmj-960	254	3	m.	PERSON
ghmj-960	254	4	i.	PERSON
ghmj-960	254	5	m.	PERSON
ghmj-960	254	6	2022	CARDINAL
ghmj-960	255	1	covid-19	ORG
ghmj-960	257	1	2022	CARDINAL
ghmj-960	258	1	11(7):1822	DATE
ghmj-960	260	1	https://www.sciencedirect.com/journal/journal-of-allergy-and-clinical-immunology/vol/149/issue/1	PERSON
ghmj-960	260	2	https://onlinelibrary.wiley.com/toc/20504527/2022/10/2	ORG
ghmj-960	260	3	https://doi.org/10.1111/bjd.20639	PERSON
ghmj-960	260	4	65	CARDINAL
ghmj-960	260	5	2023	CARDINAL
ghmj-960	260	6	6	CARDINAL
ghmj-960	260	7	2	CARDINAL
ghmj-960	260	8	j. m.	PERSON
ghmj-960	260	9	2021	CARDINAL
ghmj-960	261	1	covid-19	PERSON
ghmj-960	262	1	39	CARDINAL
ghmj-960	262	2	4, july	DATE
ghmj-960	262	3	august 2021	DATE
ghmj-960	262	4	674	CARDINAL
ghmj-960	263	1	l.	PERSON
ghmj-960	263	2	kaya	PERSON
ghmj-960	263	3	z.	PERSON
ghmj-960	263	4	2022	CARDINAL
ghmj-960	264	1	covid-19	PRODUCT
ghmj-960	265	1	2022	CARDINAL
ghmj-960	265	2	2(2	CARDINAL
ghmj-960	265	3	9	CARDINAL
ghmj-960	266	1	macy	ORG
ghmj-960	266	2	e., pandya	PERSON
ghmj-960	266	3	s.	PERSON
ghmj-960	266	4	j.	PERSON
ghmj-960	266	5	m.shi	GPE
ghmj-960	266	6	j., chung	GPE
ghmj-960	266	7	j.,et al	PERSON
ghmj-960	266	8	2022	CARDINAL
ghmj-960	267	1	covid-19	PRODUCT
ghmj-960	268	1	the journal of allergy	ORG
ghmj-960	268	2	10	CARDINAL
ghmj-960	268	3	3	CARDINAL
ghmj-960	268	4	827	CARDINAL
ghmj-960	269	1	schaffer	PERSON
ghmj-960	269	2	p.r.	GPE
ghmj-960	269	3	whelan	PERSON
ghmj-960	269	4	p. nuovo	PERSON
ghmj-960	269	5	2021	CARDINAL
ghmj-960	270	1	covid-19	PRODUCT
ghmj-960	271	1	39	CARDINAL
ghmj-960	271	2	6, november–	DATE
ghmj-960	271	3	december 2021	DATE
ghmj-960	271	4	966	CARDINAL
ghmj-960	272	1	j., laurence	ORG
ghmj-960	272	2	j.	PERSON
ghmj-960	272	3	j.	PERSON
ghmj-960	272	4	2021	CARDINAL
ghmj-960	273	1	covid-19	DATE
ghmj-960	273	2	39	CARDINAL
ghmj-960	273	3	6, november–	DATE
ghmj-960	273	4	december 2021	DATE
ghmj-960	273	5	934-965	PRODUCT
ghmj-960	274	1	n., diab	ORG
ghmj-960	274	2	r.	NORP
ghmj-960	274	3	mardani	PERSON
ghmj-960	274	4	jamali	PERSON
ghmj-960	274	5	a.	PERSON
ghmj-960	274	6	2022	CARDINAL
ghmj-960	276	1	dermatologic therapy.2022;35	PERSON
ghmj-960	277	1	pitlick	GPE
ghmj-960	277	2	m.m.	GPE
ghmj-960	277	3	joshi	PERSON
ghmj-960	277	4	a.y.	GPE
ghmj-960	277	5	gonzalez-estrada	PERSON
ghmj-960	277	6	a.	PERSON
ghmj-960	277	7	s.e.	GPE
ghmj-960	277	8	2022	CARDINAL
ghmj-960	278	1	covid-19	DATE
ghmj-960	279	1	43	CARDINAL
ghmj-960	279	2	1	CARDINAL
ghmj-960	279	3	1	CARDINAL
ghmj-960	280	1	40-43(4	DATE
ghmj-960	281	1	https://doi.org/10.2500/aap.2022.43.210101 pourani	PERSON
ghmj-960	281	2	shahidi dadras	PERSON
ghmj-960	281	3	diab	PERSON
ghmj-960	281	4	n	ORG
ghmj-960	281	5	f.	PERSON
ghmj-960	281	6	2022	CARDINAL
ghmj-960	282	1	covid-19	ORG
ghmj-960	282	2	867	CARDINAL
ghmj-960	284	1	2022	CARDINAL
ghmj-960	284	2	35	CARDINAL
ghmj-960	284	3	2):e15223	LAW
ghmj-960	285	1	doi:10.1111	ORG
ghmj-960	285	2	t.	GPE
ghmj-960	285	3	wongtada	GPE
ghmj-960	285	4	krithin	GPE
ghmj-960	285	5	s.	GPE
ghmj-960	285	6	2022	CARDINAL
ghmj-960	285	7	35,229	CARDINAL
ghmj-960	285	8	covid-19	PRODUCT
ghmj-960	286	1	36	CARDINAL
ghmj-960	287	1	a.	PERSON
ghmj-960	287	2	s.	PERSON
ghmj-960	287	3	müller	PERSON
ghmj-960	287	4	l., adams	PERSON
ghmj-960	287	5	albrecht	GPE
ghmj-960	288	1	al	ORG
ghmj-960	288	2	2021	CARDINAL
ghmj-960	289	1	covid-19	DATE
ghmj-960	290	1	the european academy	ORG
ghmj-960	290	2	jeadv	PERSON
ghmj-960	290	3	35(11	DATE
ghmj-960	290	4	e743	DATE
ghmj-960	291	1	https://doi.org/10.1111/jdv.17549 suan	PERSON
ghmj-960	291	2	d.	NORP
ghmj-960	291	3	lee	PERSON
ghmj-960	291	4	2022	CARDINAL
ghmj-960	293	1	springer allergo j int	PERSON
ghmj-960	294	1	2022	CARDINAL
ghmj-960	295	1	j.	PERSON
ghmj-960	295	2	t., punyaratabandhu	ORG
ghmj-960	295	3	palapinyo	GPE
ghmj-960	295	4	s.	PERSON
ghmj-960	295	5	s.	PERSON
ghmj-960	296	1	2022	CARDINAL
ghmj-960	296	2	covid-19	PERSON
ghmj-960	297	1	clin exp dermatol	ORG
ghmj-960	297	2	47	CARDINAL
ghmj-960	297	3	735	CARDINAL
ghmj-960	298	1	bauer, a.	PERSON
ghmj-960	298	2	wedi	GPE
ghmj-960	298	3	b.	PERSON
ghmj-960	298	4	r.	NORP
ghmj-960	298	5	pfuetzner	PERSON
ghmj-960	298	6	w.	PERSON
ghmj-960	298	7	k.	PERSON
ghmj-960	298	8	2021	CARDINAL
ghmj-960	299	1	covid-19	PRODUCT
ghmj-960	299	2	germany	GPE
ghmj-960	300	1	allergologie	ORG
ghmj-960	300	2	5	CARDINAL
ghmj-960	301	1	t., hamzah	ORG
ghmj-960	301	2	a. l.	PERSON
ghmj-960	301	3	m. aquailina	PERSON
ghmj-960	301	4	s.	GPE
ghmj-960	301	5	asero	GPE
ghmj-960	301	6	r.	NORP
ghmj-960	301	7	2022	CARDINAL
ghmj-960	303	1	wileyallergy	PERSON
ghmj-960	303	2	2022;77:734–766	CARDINAL
ghmj-960	304	1	a. & budiyanti	ORG
ghmj-960	304	2	r.t.	PERSON
ghmj-960	304	3	2023	CARDINAL
ghmj-960	305	1	postcovid-19	CARDINAL
ghmj-960	306	1	ghmj	PERSON
ghmj-960	306	2	global health management journal	ORG
ghmj-960	306	3	6(2	CARDINAL
ghmj-960	307	1	57–65	CARDINAL